{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:43:08Z","timestamp":1648813388702},"reference-count":31,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.transci.2013.01.019","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T17:20:25Z","timestamp":1361208025000},"page":"163-167","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Daily vs every other day administration of G-CSF following autologous peripheral stem cell transplantation: A prospective randomized study"],"prefix":"10.1016","volume":"49","author":[{"given":"Hasan Atilla","family":"Ozkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufuk Guney","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cengiz","family":"Bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafer","family":"Gulbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2013.01.019_b0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.1989.7.9.1288","article-title":"Regimen-related toxicity and early transplant survival in patients undergoing marrow transplantation for lymphoma","volume":"7","author":"Bearman","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0010","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1097-0142(19881201)62:11<2445::AID-CNCR2820621133>3.0.CO;2-I","article-title":"Analysis of early infectious complications after autologous bone marrow transplantation","volume":"62","author":"Kirk","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2013.01.019_b0015","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM199106203242504","article-title":"Recombinant granulocyte macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid cancer","volume":"324","author":"Nemunaitidis","year":"1991","journal-title":"New Engl J Med"},{"key":"10.1016\/j.transci.2013.01.019_b0020","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1200\/JCO.1994.12.9.1931","article-title":"Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high risk lymphoid malignancies","volume":"12","author":"Stahel","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0025","first-page":"307","article-title":"Randomized vehicle controlled dose finding study of glycosylated recombinant human granulocyte colony stimulating factor after bone marrow transplantation","volume":"11","author":"Linc","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1200\/JCO.1997.15.2.451","article-title":"Low dose filgrastim significantly enhances neutrophil recovery following autologous peripheral blood stem cell transplantation in patient with lymphoproliferative disorders: evidence for clinical and economic benefit","volume":"15","author":"McQuaker","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0035","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.1995.13.6.1323","article-title":"Granulocyte colony stimulating factor accelerates neutrophil engraftment following peripheral blood stem cell transplantation: a prospective, randomized trial","volume":"13","author":"Klumpp","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.1995.13.4.935","article-title":"Granulocyte colony stimulating factor following peripheral blood progenitor cell transplant in non-Hodgkin\u2019s Lymphoma","volume":"13","author":"Cortelazzo","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.1994.12.4.661","article-title":"Randomized study of growth factors post peripheral blood stem cell transplant: neutrophil recovery is improved with modest clinical benefit","volume":"12","author":"Spitzer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1701104","article-title":"G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs","volume":"21","author":"Tarella","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0055","first-page":"533","article-title":"Administration of G-CSF can be delayed after transplantation of autologous G-CSF primed blood stem cells: a randomized study","volume":"17","author":"Faucher","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bmt.1700947","article-title":"Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation","volume":"20","author":"Cetkovsky","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.bmt.1701100","article-title":"Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial","volume":"21","author":"Bolwell","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0070","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bmt.1701469","article-title":"A randomized trial of granulocyte colony stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation","volume":"22","author":"Bence-Bruckler","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00000421-200102000-00003","article-title":"Use of granulocyte colony stimulating factor after high dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?","volume":"24","author":"Ener","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705097","article-title":"Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomized trial","volume":"36","author":"Valteau-Couanet","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0085","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/pbc.22394","article-title":"Delayed administration of filgrastim (G-CSF) following autologous peripheral blood stem cell transplantation (APBSCT) in pediatric patients does not change time to neutrophil engraftment and reduces use of G-CSF","volume":"54","author":"Pai","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2013.01.019_b0090","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.bmt.1703079","article-title":"Administration of post-autologous PBSCT rhG-CSF is associated with long-term low concentrations of bone marrow hematopoietic cells","volume":"27","author":"Osma","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bmt.1703538","article-title":"A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantation","volume":"29","author":"de Azevedo","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bmt.1701203","article-title":"Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation","volume":"21","author":"Colby","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1703539","article-title":"The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant period","volume":"29","author":"Hornedo","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0110","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V78.11.2791.bloodjournal78112791","article-title":"Granulocyte colony stimulating factor and its receptor","volume":"78","author":"Demetri","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.01.019_b0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.1995.tb05344.x","article-title":"Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy+G-CSF","volume":"91","author":"Tarella","year":"1995","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.transci.2013.01.019_b0120","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood.V88.7.2775.bloodjournal8872775","article-title":"Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow","volume":"88","author":"Ottinger","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.transci.2013.01.019_b0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/scd.1.1996.5.351","article-title":"Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72h","volume":"5","author":"Murea","year":"1996","journal-title":"J Hematother"},{"key":"10.1016\/j.transci.2013.01.019_b0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.bmt.1701481","article-title":"Analysis of rhG-CSF-effects on platelets by in vitro bleeding test and transcranial Doppler ultrasound examination","volume":"22","author":"S\u00f6hngen","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2013.01.019_b0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1200\/JCO.2004.06.102","volume":"22","author":"Ringden","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2013.01.019_b0140","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/TP.0b013e3181f585c7","article-title":"Granulocyte colony-stimulating factor induced acute and chronic graft-versus-host disease","volume":"90","author":"Ringden","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2013.01.019_b0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0140-6736(93)90394-V","article-title":"Granulocyte colony-stimulating factor and platelet aggregation","volume":"341","author":"Shimoda","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2013.01.019_b0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/09537104.2010.485255","article-title":"Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans","volume":"21","author":"Spiel","year":"2010","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.transci.2013.01.019_b0155","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1160\/TH10-08-0530","article-title":"Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomized controlled trial","volume":"105","author":"Spiel","year":"2011","journal-title":"Thromb Haemost"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T21:56:25Z","timestamp":1644357385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050213000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1473050213000359"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.01.019","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily vs every other day administration of G-CSF following autologous peripheral stem cell transplantation: A prospective randomized study","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}